Welcome to our dedicated page for Proassurance Cp news (Ticker: PRA), a resource for investors and traders seeking the latest updates and insights on Proassurance Cp stock.
ProAssurance Corporation (NYSE: PRA) is a specialty property and casualty insurer with a primary focus on medical professional liability, products liability for medical technology and life sciences, and workers’ compensation insurance. This news page aggregates company-issued releases and other coverage so readers can follow developments affecting PRA stock and ProAssurance’s insurance operations.
Recent ProAssurance news has centered on quarterly financial results and the company’s pending acquisition by The Doctors Company. Earnings releases detail net income, Non-GAAP operating income, combined ratios, segment performance for Specialty Property and Casualty and Workers’ Compensation Insurance, and changes in net investment income. These updates provide insight into underwriting trends, reserve development, pricing actions in the medical professional liability market, and the contribution of investment returns to overall results.
Another key news theme is the proposed merger with The Doctors Company. ProAssurance has reported stockholder approval of the merger agreement and the early termination of the Hart-Scott-Rodino waiting period by the U.S. Federal Trade Commission. Joint releases describe the strategic rationale for combining ProAssurance’s specialty insurance capabilities with The Doctors Company’s physician-owned medical malpractice platform, while emphasizing that both organizations will operate independently until closing and that the transaction remains subject to regulatory approvals.
Investors and observers can use this page to review ProAssurance’s own announcements, including updates on the merger process, segment-level performance, and capital measures such as book value per share. By checking this news feed regularly, readers can monitor how ProAssurance navigates conditions in the medical professional liability and workers’ compensation markets and track milestones in its planned transition to a wholly owned subsidiary of The Doctors Company.
NexPoint Real Estate Finance (NYSE:NREF) has declared a dividend of $0.53125 per share for its 8.50% Series A Cumulative Redeemable Preferred Stock (NYSE: NREF PRA). The dividend is scheduled for payment on October 27, 2025, to stockholders recorded as of the close of business on October 15, 2025.
ProAssurance (NYSE:PRA) reported strong Q2 2025 results with net income of $21.9 million ($0.42 per diluted share) and operating income of $26.8 million ($0.52 per diluted share). The company demonstrated significant progress in its medical professional liability and workers' compensation markets.
Key highlights include stable net premiums written of $135.9 million in Medical Professional Liability business, 10% premium increases in Specialty P&C segment, and an 81% retention rate. The consolidated Non-GAAP combined ratio improved by 9.5 percentage points year-over-year. Book value per share increased to $24.80, up from $23.49 at year-end 2024.
The company's pending merger with The Doctors Company received stockholder approval and FTC clearance, with expected closing in H1 2026.
Flagstar Financial (NYSE: FLG) has declared quarterly cash dividends for its common and preferred stocks. The company announced a common stock dividend of $0.01 per share, payable on September 17, 2025, to stockholders of record as of September 7, 2025.
Additionally, the bank declared dividends for three preferred stock series: Series A at $15.94 per share ($0.3984 per depositary share), Series B at $3.3333 per share, and Series D at $3.3333 per share. As of June 30, 2025, Flagstar reported $92.2 billion in assets, $64.4 billion in loans, and $69.7 billion in deposits.
ProAssurance Corporation (NYSE: PRA) and The Doctors Company have achieved a significant milestone in their pending acquisition deal with the early termination of the Hart-Scott-Rodino waiting period by the U.S. Federal Trade Commission on July 2, 2025.
The Doctors Company, the largest physician-owned medical malpractice insurer in the U.S., is set to acquire ProAssurance, a specialty insurer focused on medical liability, medical technology products liability, and workers' compensation insurance. The transaction is expected to close in the first half of 2026, subject to remaining regulatory approvals and other customary closing conditions.
ProAssurance Corporation (NYSE: PRA) announced that stockholders have overwhelmingly approved its proposed acquisition by The Doctors Company, with over 99% of shares voting in favor. The transaction is expected to close in the first half of 2026, subject to regulatory approvals including Hart-Scott-Rodino Act requirements and state insurance regulators' approval.
Upon completion, PRA will delist from NYSE and become a wholly owned subsidiary of The Doctors Company. The merger aims to combine both companies' strengths in the medical professional liability marketplace, with no financing conditions attached.
Flagstar Financial (NYSE: FLG) has declared its quarterly cash dividends for both common and preferred stockholders. The company announced a $0.01 per share dividend on common stock, payable June 17, 2025, to stockholders of record as of June 7, 2025.
Additionally, preferred stock dividends were declared:
- Series A preferred stock: $15.94 per share ($0.3984 per depositary share)
- Series B preferred stock: $3.3333 per share
- Series D preferred stock: $3.3333 per share
As of March 31, 2025, Flagstar reported total assets of $97.6 billion, loans of $67.1 billion, deposits of $73.9 billion, and stockholders' equity of $8.2 billion. The bank operates approximately 400 locations across nine states, focusing on the New York/New Jersey metro area, upper Midwest, Florida, and West Coast.
ProAssurance (NYSE: PRA) will be acquired by The Doctors Company Insurance Group (TDC Group), as announced on March 19, 2025. The transaction is expected to close in the first half of 2026, subject to regulatory approval. Following the acquisition, PRA will be 100% owned by The Doctors Company.
AM Best has confirmed that ProAssurance's Financial Strength Rating of A (Excellent) and Long-Term Issuer Credit Ratings of 'a+' (Excellent) remain unchanged, with a stable outlook. The ratings reflect ProAssurance's strongest balance sheet strength, adequate operating performance, favorable business profile, and appropriate enterprise risk management.
The merger combines the fourth-largest medical professional liability (MPL) insurance writer (ProAssurance) with the second-largest (TDC Group) in the United States, based on direct premiums written. AM Best will continue monitoring both organizations independently during the extended transaction period.